Affordable Access

Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.

Authors
  • Hyett, J
  • Perdu, M
  • Sharland, G
  • Snijders, R
  • Nicolaides, K H
Type
Published Article
Journal
BMJ (Clinical research ed.)
Publication Date
Jan 09, 1999
Volume
318
Issue
7176
Pages
81–85
Identifiers
PMID: 9880278
Source
Medline
License
Unknown

Abstract

Measurement of fetal nuchal translucency thickness-traditionally used to identify fetuses at high risk of aneuploidy-at 10-14 weeks of gestation can identify a large proportion of fetuses with major defects of the heart and great arteries.

Report this publication

Statistics

Seen <100 times